NCT02899546 (Septi-PICC) is a clinical trial in Catheterization, sponsored by Centre Hospitalier Universitaire de la Réunion.

Who is sponsoring NCT02899546?

NCT02899546 is sponsored by Centre Hospitalier Universitaire de la Réunion.

What condition does NCT02899546 study?

NCT02899546 studies Catheterization, Peripheral, Infection.

Is NCT02899546 still recruiting?

NCT02899546 is currently completed. Last updated 5 September 2018.

Last reviewed 2018-09-05 · How we verify

NCT02899546: Septi-PICC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Peripherally Inserted Central Catheter (PICC)-Related Infections in a Tropical Area

Completed Last updated 5 September 2018

What this trial tests

trial in Catheterization in 283 participants. Completed in 30 October 2016.

Timeline

1 November 2015

Primary endpoint
30 October 2016

30 October 2016

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de la Réunion
Status	Completed
Study type	OBSERVATIONAL
Enrollment	283
Start date	1 November 2015
Primary completion	30 October 2016
Estimated completion	30 October 2016
Sites	1 location across France

Conditions studied

Catheterization — all drugs for Catheterization →
Peripheral — all drugs for Peripheral →
Infection — all drugs for Infection →

Sponsor

Centre Hospitalier Universitaire de la Réunion

Who can join

18 and older, any sex, with Catheterization or Peripheral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Septi-PICC study aims at assessing incidence of Peripherally Inserted Central Catheter (PICC)-related infections among patients managed in the University Hospital of La Reunion for PICC setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de la Réunion trials

Trials by the same sponsor.

NCT06697262 — Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia · NA · not yet recruiting
NCT07444515 — Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients. · NA · not yet recruiting
NCT07190560 — Against Chikungunya Virus and Neonatal Infection · NA · not yet recruiting
NCT07365670 — Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Int · NA · not yet recruiting
NCT06485310 — Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary M · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02899546 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion
Last refreshed: 5 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02899546.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing